Filing Details
- Accession Number:
- 0001144204-18-033791
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-11 17:37:56
- Reporting Period:
- 2018-06-08
- Accepted Time:
- 2018-06-11 17:37:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1644963 | Avenue Therapeutics Inc. | ATXI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
941841 | Md A Lindsay Rosenwald | C/O Avenue Therapeutics, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-06-08 | 5,234 | $4.34 | 25,234 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Weighted average price. These shares were purchased in multiple transactions ranging from $4.20 to $4.40. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.
- Includes 10,000 shares of restricted stock.